Cardio3: Moving from Science Project to Business Model in Stem Cells

Cardiac stem cell therapy for regenerating diseased heart tissue has been long on promise but short on delivery. A Belgian incubator and start-up hope to finally bring this treatment to market.

More from Business Strategy

More from In Vivo